Navigation Links
Effectene Transfection Reagent

For transfection of a wide variety of cells, particularly effective for primary cells

Features and benefits
  • Fast and easy transfection
  • No transfection-complex removal needed for most cell lines
  • Transfection in the presence of serum
  • Ideal for primary cells or sensitive cell lines
  • High transfection efficiencies and minimal cytotoxicity
  • Low DNA requirement
Principle

Effectene Transfection Reagent is an innovative non-liposomal lipid formulation that is used in conjunction with a special DNA-condensing enhancer and optimized buffer to achieve high transfection efficiencies. The enhancer first condenses the DNA molecules and Effectene Reagent subsequently coats them with cationic lipids (see figure "Model of Effectene Principle"), providing a particularly efficient way of transferring DNA into eukaryotic cells. Effectene Reagent offers significant advantages over many liposome reagents and other transfection methods (1, 2).

Model of Effectene Principle

High Transfection Efficiencies Using Effectene Reagent
Comparison of transfection efficiencies using Effectene Reagent and two commonly used lipid-based reagents. Murine teratocarcinoma F9 cells (5 x 105) were transfected in 6-well plates with a luciferase-reporter plasmid using optimized conditions based on the manufacturer's instructions for each reagent. Transfection efficiencies were determined by measuring luciferase activity 48 h post-transfection, and are given as relative light units (RLU). (Data kindly provided by I. Clavereau, D. Petitprez, and I. Van Seuningen, Unit INSERM 377, Place de Verdun, Lille Cedex, France.)


Transfection of Oligonucleotides Using Effectene Reagent



C6 glioblastoma cells (1 x 104) were transfected with either naked FITC-labeled CD44 antisense oligodeoxynucleotide (ODN) or with EffecteneODN complexes. Intracellular accumulation and distribution of the transfected ODNs was analyzed 16 h post-transfection by immunofluoresence. A Naked ODNs (2 g). B ODNs (0.04 g) complexed with Effectene Reagent. Transfected ODNs are green in the photos. (Data kindly provided by G. Beutel and M. Schott, Institute of Neuropathology, Hanover Medical School, Hanover, Germany.)

Procedure

The Effectene procedure has two steps. DNA is first mixed with Enhancer and a buffer that provides optimal salt conditions for efficient DNA condensation. This step requires just 25 minutes. Effectene Reagent is then added and the mixture is incubated for 510 minutes to allow EffecteneDNA complexes to form. The complexes are mixed with growth medium (which can contain serum and antibiotics), and added directly to the cells. The cells are then incubated until harvested and analyzed for gene expression.

Applications

Effectene Reagent is suitable for transient and stable transfection of a broad range of cell types (see figures "High Transfection Efficiencies Using Effectene Reagent" and "Transfection of Oligonucleotides Using Effectene Reagent"). Because transfection can be performed in the presence of serum and requires low amounts of DNA (see figure "Serum and DNA Quantity vs. Transfection Efficiency"), cytotoxicity is minimal. This makes Effectene Reagent particularly effective for primary cells (see figure "Effectene Reagent with Primary Cells"). A searchable list of cell lines and primary cells successfully transfected using Effectene Reagent, as well as customer-developed transfection protocols, is available at the Transfection Tools web site www.qiagen.com/transfectiontools/.

Serum and DNA Quantity vs. Transfection Efficiency



Influence of serum and DNA quantity on transfection using Effectene Reagent. 2 x 104 COS-7 cells were seeded per well in 96-well plates one day before transfection. Cells were transfected using 0.011.0 g of a beta-galactosidasereporter plasmid and 0.088.0 l Enhancer (DNA: Enhancer ratio of 1:8) and 2 l Effectene Reagent, in either the presence or absence of serum. Each bar represents the average efficiency from four replicates 48 h post-transfection.

Effectene Reagent with Primary Cells



Expression of green fluorescent protein (GFP) in primary rabbit aortic smooth muscle cells transfected using Effectene Reagent. 1 x 105 cells were seeded one day prior to transfection, and transfections were performed in 6-well plates using 0.4 g of a GFP-reporter plasmid and 10 l Effectene Reagent per well. Cells were viewed 24 h post-transfection by fluorescence microscopy. Approximately 40% of the cells were transfected, as determined by FACS analysis. (Data kindly provided by K. Veit, 2nd Medical Clinic, Dept. Clinical Pharmacology, Mainz, Germany.)

High-throughput transfection

The application of recombinant DNA technology to fields such as drug discovery and development has led to an increased need for high-throughput transfection. Transfection using Effectene Reagent requires low amounts of DNA and minimal handling, and in addition, removal of transfection complexes is not required, making this reagent highly suitable for high-throughput screening. Effectene Reagent provides outstanding transfection efficiencies, excellent reproducibility, and minimal cytotoxicity in high-throughput transfection, and is available in bulk quantities.

Cited References

1. Ausubel, F.M., et al. eds. (1991) Current Protocols in Molecular Biology, Wiley Interscience, New York.
2. Sambrook, J., Fritsch, E.F., and Maniatis, T., eds. (1989) Molecular cloning a laboratory manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.



'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Effectene Transfection Reagent provides efficient gene delivery to primary neuronal cell cultures
2. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
3. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
4. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
5. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
6. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
7. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
8. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
9. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
10. Efficient Transfection of Neurospora Crassa
11. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Effectene Transfection Reagent

(Date:12/2/2009)... Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ... previously announced unit offering, the underwriters have exercised in ... units. Each unit is comprised of one common share ... was sold at a price of US$3.00 per unit. ...
(Date:12/2/2009)... December 2 Pepscan Holding NV,the Netherlands based biotechnology ... immune therapeutics today announced that it,has appointed Wim E.M. ... Dr. Mol will be responsible for ... strategic direction of the company. He brings to,Pepscan more ...
(Date:12/2/2009)... Israel, December 2 Gamida Cell announced today,a ... and,efficacy of a gene therapy product which combines ... The product may have potential to,treat inherited anemias ... Gamida Cell is developing a series of ...
(Date:12/2/2009)... RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald ... leading,producer and distributor of infant and children,s formula, milk ... Company will be featured,in the Spring issue of US ... of over 250,000 executives in the food and beverage ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Dutch Biotech Company Pepscan Appoints New CEO 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
... up 31 percent for quarter ConjuGon CEO to ... Canadian cancer drug Wisconsin DOA buys Seritis software ... Web site GE Healthcare profits up ... 31 percent from the same quarter last year, the company has ...
... National Park Service. Middleton, Wis. ... on DNA cloning, has landed federal support to commercialize enzymes ... in Yellowstone National Park. , ,The U.S. Department of Energy's ... sequence genetic data that will help Lucigen sort through the ...
... Milken Institute predicts moderate Wisconsin biopharmaceutical growth ... Third Wave appoints regulatory director ... growth ,Wisconsin is home to significant biopharmaceutical innovation ... to a recent report prepared by the ...
Other Biology Technology:Tech Digest: whats moving in the Midwest 2Tech Digest: whats moving in the Midwest 3Tech Digest: whats moving in the Midwest 2
(Date:12/4/2009)... Dr. Daniel Leskovar, a Texas AgriLife Research plant ... in Uvalde, has been investigating ways to help vegetable ... to the field. , "This research can aid in ... of some vegetable crops by producing high-quality, more adaptive ...
(Date:12/4/2009)... By measuring the total gene activity in organs relevant ... medical university Karolinska Institutet have identified a module of ... blood cells into the atherosclerotic plaque. The findings, which ... PLoS Genetics , suggest that targeting the migration of ...
(Date:12/4/2009)... (EEG) is widely used by physicians and scientists to ... it has remained largely unknown whether the electrodes on ... happening inside the brain. Scientists at the Max Planck ... found a crucial link between the activity generated within ...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Scientists discover gene module underlying atherosclerosis development 2How to read brain activity? 2Frost 26 Sullivan 3A Self Monitoring and POC Diabetes Tests Reveal Potential for Significant Growth Boosting the European Diabetes Diagnostics Marke 49710 1Frost 26 Sullivan 3A Self Monitoring and POC Diabetes Tests Reveal Potential for Significant Growth Boosting the European Diabetes Diagnostics Marke 49710 2Frost 26 Sullivan 3A Self Monitoring and POC Diabetes Tests Reveal Potential for Significant Growth Boosting the European Diabetes Diagnostics Marke 49710 3One of a Kind Marketing and Sales Summit for Dentists Announced 49706 1One of a Kind Marketing and Sales Summit for Dentists Announced 49706 2One of a Kind Marketing and Sales Summit for Dentists Announced 49706 3BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 1BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 2BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 3BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 4
... 1 Supply Chain Council (SCC) announced ... for Operations Management to offer a unique new program ... chain and operations management professionals.SCC is the world,s leading ... on the SCOR(R) standard while APICS is the leader ...
... May 8 Military and civilian personnel from the ... local homeland security, law enforcement and other first-responder personnel ... been encouraged to register and attend the 2009 Force ... held at Stafford Regional Airport and Marine Corps Base, ...
... Providers Team Up to Provide High Volume Transaction ... SHORES, Calif. and NEW YORK, May 11 ... Board: CICI), a leading supplier of electronic signature ... industry* and the recognized leader** in biometric signature ...
Other Biology News:Supply Chain Council Partners With APICS The Association for Operations Management 2Demonstration Features Commercial Technology for Combating Terrorism 2Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 2Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 3Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 4Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 5